ARCHIVES

Harold Varmus Addresses the NCI Board of Scientific Advisors

This article is from The Cancer Letter archive.

Vol. 39 No. 10 | March 8, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

DCE Concepts Approved

March 7, 1986

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014

Firm Reports Limited Market For Self-Test Detection Methods

July 29, 1983

Quality Of Care Varies Widely For Prostate Cancer, Study Says

August 29, 2008

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011